“Approximately 1.7 million Australians aged 18 years and older have chronic kidney disease. Some of these people are at a higher risk of further decline in kidney function – also known as progression of chronic kidney disease – to the point of needing dialysis or kidney transplantation. More than 3,000 Australians develop kidney failure requiring dialysis each year and there are currently more than 13,000 Australians receiving dialysis.”
the prevalence is shocking!! Once The current trials have settled, MSB can focus on many of these diseases. Unless the company goes broke, I can see it will Be busy for the next at least 20 years. I hope to hold until I retire comfortably.
Cell Therapy News/Articles, page-3804
-
- There are more pages in this discussion • 14,458 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |